Metabolon, Charles River Partner on Cancer Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Metabolon and Charles River Discovery Services are partnering to advance cancer research.

The deal, which was officially announced this week, leverages Metabolon's metabolomics technology with Charles River's preclinical oncology expertise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.

The Wall Street Journal reports that Walgreens didn't fully vet Theranos before entering partnership.

Jeremy Berg is to be the next editor in chief of Science magazine.

Regeneron Pharmaceuticals is to be the new sponsor of the prestigious high school Science Talent Search competition, according to the New York Times.